• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

IM Sales Call tomorrow

































It is crystal clear to anyone watching that this whole thing has been completely mismanaged. Jim and John are incompetent dunces. The definition of poor leadership. What a joke.